Evonile Pharma ne **10.28 million** shares ka rights issue nikala hai. Stock ka price **₹860** rakha gaya hai taaki company apna karza kam kar sake.
Rights Issue ka pura hisab-kitab
Evonile Pharma Ltd ne total ₹8,847.54 million raise karne ka faisla kiya hai. Agar aap 11 November 2026 tak shareholder the, toh aap isme apply kar sakte hain. Ratio 5:12 ka hai, matlab har 12 shares par aapko 5 rights shares milenge. Payment ka system thoda alag hai—75% (yani ₹645) abhi dena hai aur baki 25% (yani ₹215) baad mein first and final call par dena hoga.
Paisa kahan jayega?
Company ka main target hai debt kam karna. Lagbhag ₹8,000 million ka fund company apne purane udhaar aur interest chukane mein lagayegi. Jab se control WaveRise Investments aur ChrysCapital Fund X ke haath mein aaya hai, tab se company apni balance sheet sudharne par lagi hai.
Kuch risks jo ignore mat karna
Company filhal kuch legal pange mein hai, jinme tax aur criminal cases shamil hain. Inke upar ₹416.2 million ki contingent liability hai DPCO cases ki wajah se. Saath hi, ye ek 'asset-light' model par kaam karte hain, toh agar contract manufacturer ke saath koi issue hua, toh supply chain ladkhada sakti hai.
Zaruri Dates yaad rakho:
- Issue Opens: 19 November 2026
- Issue Closes: 3 December 2026
- Allotment: 4 December 2026
- Listing: 9 December 2026